Despite the different genetic causes of SMA and SBMA, both exhibit liver damage and functional deficit in the IGF1 pathway, suggesting a potential link between fatty liver, insulin resistance, IGF1, and neuromuscular damage. The gene discussed is IGF1; the disease is proximal spinal muscular atrophy.